ONCOMARK LIMITED - Ireland 

Ranking results:

Past rankings:

2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:900-1000
Total Number of Projects:69
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:800-900
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2009
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 9
As coordinator: 0
As participant: 8
Sole participant: 1
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2016 2.751.250 0 2.751.250 1
2015 0 885.000 0 1
2014 0 3.605.357 265.675 1
2013 0 1.814.000 302.333 1
2012 0 8.998.638 1.126.297 2
2011 0 7.944.113 1.529.879 2
2010 0 1.762.399 493.891 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN7
ROYAL COLLEGE OF SURGEONS IN IRELAND5
KATHOLIEKE UNIVERSITEIT LEUVEN2
LUNDS UNIVERSITET2
OPTIMATA2
PINTAIL2
RUPRECHT KARLS UNIVERSITAET HEIDELBERG2
STICHTING VU2
THE QUEEN'S UNIVERSITY OF BELFAST2
VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG2
ACADEMISCH ZIEKENHUIS GRONINGEN1
AGENDIA NV1
BAYER1
BAYER SCHWEIZ1
BEATSON INSTITUTE FOR CANCER RESEARCH LBG1
DANISH CANCER SOCIETY1
EPIGENOMICS1
F HOFFMANNLA ROCHE1
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON1
GENENTECH INC1
ICON PLC1
INSTITUT CURIE1
IPATH DIAGNOSTICS LIMITED1
IRISH CLINICAL ONCOLOGY RESEARCH GROUP LIMITED LBG1
KLINIKUM DER JOHANN WOLFGANG GOETHE UNIVERSITAET1
MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV1
MOSAIQUES DIAGNOSTICS1
PATHOLOGY DIAGNOSTICS1
PATHOLOGY EXPERTS1
PROTATOUANS ETAIREIA EREYNAS VIOTECHNOLOGIAS MONOPROSOPI ETAIREIA PERIORISMENIS EYTHINIS1
SOMANTIX BV1
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS1
TECHNISCHE UNIVERSITAET DRESDEN1
THE BEATSON INSTITUTE FOR CANCER RESEARCH1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE1
UNIVERSITE DU LUXEMBOURG1
UNIVERSITE PARIS DESCARTES1
UPPSALA UNIVERSITET1
VIB1

Constancy:

Total number of partners: 57
Partner loyalty:
Frequent Partner: (> 2 projects): 12
Rare Partner: 45
Frequent / Rare Partner Ratio: 0.27

Project overview:

Start dateProjectacronymrolefundingpartners
2016-02-01OncoMasTR - Novel Prognostic Assay for Early Stage Breast Cancer OncoMasTRcoordinator2.751.2501
2015-07-01Fellowship Programme supporting Career Development and Interdisciplinary Training in Omics driven Personalised Medicine TOPMed10participant885.0007
2014-12-01Exploiting MELanoma disease comPLEXity to address European research training needs in translational cancer systems biology and cancer systems medicine MEL-PLEXparticipant3.605.35710
2013-11-01SYSTEMS-BASED VIEW OF MELANOMA PROGRESSION: TOWARDS NOVEL DIAGNOSTIC (AND THERAPEUTIC) APPLICATIONS SYS-MELparticipant1.814.0006
2012-11-01Apoptosis Modelling for Treatment Decisions in Colorectal Cancer APO-DECIDEparticipant2.999.4827
2012-02-01Predictive Genomic Biomarkers Methods for Combination Bevacizumab (Avastin) Therapy in Metastatic Colorectal Cancer ANGIOPREDICTparticipant5.999.15611
2011-11-01Fast-Tracking Pathology via Automated Image Analysis and High-Performance Computing: Application to Prostate Cancer Diagnostics FAST-PATHparticipant1.948.3276
2011-01-01Rational Therapy for Breast Cancer: Individualized Treatment for Difficult-to-Treat Breast Cancer Subtypes RATHERparticipant5.995.7868
2010-07-01Histopathologic and Mechanistic Assessment of Angiogenesis Inhibitor Related Toxicities: A Cross-Sectoral, Multi-disciplinary Approach ANGIOTOXparticipant1.762.39910

Alias institution names:

  • ONCOMARK LIMITED